1. DSpace at

Browsing by Author Agrewala, J.N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
17-Jul-2022Fiction and facts about BCG imparting trained immunity against COVID-19Kaur, G.; Singh, S.; Nanda, S.; Zafar, M.A.; Malik, J.A.; Arshi, M.U.; Lamba, T.; Agrewala, J.N.
18-Jun-2019ImmtorLig_DB: repertoire of virtually screened small molecules against immune receptors to bolster host immunityChatterjee, D.; Kaur, G.; Muradia, S.; Singh, B.; Agrewala, J.N.
18-Aug-2022Immunotherapeutic role of NOD-2 and TLR-4 signaling as an adjunct to antituberculosis chemotherapyAqdas, M.; Maurya, S.K.; Pahari, S.; Singh, S.; Khan, N.; Sethi, K.; Kaur, G.; Agrewala, J.N.
14-Dec-2020A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosisMaurya, S.K.; Aqdas, M.; Das, D.K.; Singh, S.; Nadeem, S.; Kaur, G.; Agrewala, J.N.
18-Nov-2022Mycobacterium tuberculosis exploits MPT64 to generate myeloid‑derived suppressor cells to evade the immune systemSingh, S.; Maurya, S.K.; Aqdas, Md.; Bashir, H.; Arora, A.; Arora, V.; Agrewala, J.N.
18-Feb-2021Protein transduction domain functionalized gold nanoparticles for effective delivery of potent cytotoxic agent in cancer cellsBansal, K.; Devi, N.; Aqdas; Sharma, R.K.; Agrewala, J.N.; Katare, O.P.; Wangoo, N.
17-Nov-2022Targeting dendritic cells with TLR-2 ligand–coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunityDas, D.K.; Zafar, M.A.; Nanda, S.; Singh, S.; Lamba, T.; Bashir, H.; Singh, P.; Maurya, S.K.; Nadeem, S.; Sehrawat, S.; Bhalla, V.; Agrewala, J.N.
31-Aug-2018TLR-3 stimulation skews M2 macrophages to M1 through IFN-αβ signaling and restricts tumor progressionVidyarthi, A.; Khan, N.; Agnihotri, T.; Negi, S.; Das, D.K.; Md. Aqdas; Chatterjee, D.; Colegio, O.R.; Tewari, M.K.; Agrewala, J.N.
Showing results 1 to 8 of 8